Enduring CME Course: VMAT2 Inhibitors in Geriatric and Complex Populations: Mechanistic Insights, Formulation Advances, and Age-Appropriate Dosing Strategies

Activity ID

14477

Expires

December 31, 2026

Format Type

Enduring

CME Credit

Fee

CME Provider: Clinical Care Options, LLC

Description of CME Course

The goal of this activity is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with tardive dyskinesi

ABMS Member Board Approvals by Type

ABMS Lifelong Learning CME Activity

Psychiatry and Neurology

More Information

Commercial Support?

Yes

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

General Information on CME Activity

Educational Objectives

At the end of this curriculum program, learners will be able to:

1. Identify risk factors for TD that increase susceptibility in older individuals

2. Implement best practices for using screening and assessment tools with patients at risk for TD

3. Interpret screening tool results to identify TD, considering patient and caregiver reports

4. Evaluate the safety, effectiveness, and pharmacologic properties of VMAT2 inhibitors for managing TD in older adults and special populations

5. Develop an individualized treatment plan for diverse patient populations with TD

Competencies

Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

Practice Setting

Inpatient, Outpatient, Rural, Urban, VA/Military